Impact Biomedical Inc
IBO0.472USD
+0.014+2.92%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
5.75MMarket Cap
LossP/E TTM
More Details of Impact Biomedical Inc Company
Impact Biomedical, Inc. is a biotechnology company engaged in discovering, developing, and patenting healthcare solutions. It discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. It has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. It also evaluates additional technologies.
Impact Biomedical Inc Info
Ticker SymbolIBO
Company nameImpact Biomedical Inc
IPO dateSep 16, 2024
CEOHeuszel (Frank D)
Number of employees2
Security typeOrdinary Share
Fiscal year-endSep 16
Address1400 Broadfield Blvd.
CityHOUSTON
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code77084
Phone15852321500
Websitehttps://www.impactbiomedinc.com/
Ticker SymbolIBO
IPO dateSep 16, 2024
CEOHeuszel (Frank D)
Company Executives of Impact Biomedical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Director
Director
182.00
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Director
Director
--
--
Mr. Frank D. Heuszel, CPA
Mr. Frank D. Heuszel, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Suseck
Mr. Mark Suseck
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Elise Brownell
Dr. Elise Brownell
Independent Director
Independent Director
--
--
Ms. Melissa Sims
Ms. Melissa Sims
Independent Director
Independent Director
--
--
Mr. David K. Keene
Mr. David K. Keene
Independent Director
Independent Director
--
--
Mr. Christian Zimmerman
Mr. Christian Zimmerman
Independent Director
Independent Director
--
--
Mr. Castel B. Hibbert
Mr. Castel B. Hibbert
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Director
Director
182.00
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Director
Director
--
--
Mr. Frank D. Heuszel, CPA
Mr. Frank D. Heuszel, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Suseck
Mr. Mark Suseck
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Elise Brownell
Dr. Elise Brownell
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Dec 4
Updated: Thu, Dec 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Document Security Systems, Inc.
88.87%
The Vanguard Group, Inc.
0.78%
Chan (Heng Fai Ambrose)
0.34%
BlackRock Institutional Trust Company, N.A.
0.24%
Heuszel (Frank D.)
0.09%
Other
9.68%
Shareholders
Shareholders
Proportion
Document Security Systems, Inc.
88.87%
The Vanguard Group, Inc.
0.78%
Chan (Heng Fai Ambrose)
0.34%
BlackRock Institutional Trust Company, N.A.
0.24%
Heuszel (Frank D.)
0.09%
Other
9.68%
Shareholder Types
Shareholders
Proportion
Corporation
88.87%
Investment Advisor
1.06%
Individual Investor
0.43%
Hedge Fund
0.06%
Investment Advisor/Hedge Fund
0.05%
Other
9.52%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
29
1.23M
1.18%
+578.18K
2025Q3
25
542.17K
4.45%
+223.27K
2025Q2
27
5.00M
43.10%
+213.82K
2025Q1
27
9.94M
82.23%
+3.86M
2024Q4
21
6.56M
57.06%
+6.27M
2024Q3
14
6.41M
55.73%
+6.41M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Document Security Systems, Inc.
92.98M
88.87%
+92.80M
+50914.94%
Dec 22, 2025
The Vanguard Group, Inc.
102.91K
0.1%
+70.47K
+217.25%
Sep 30, 2025
Chan (Heng Fai Ambrose)
351.56K
0.34%
-3.92M
-91.76%
Apr 04, 2025
BlackRock Institutional Trust Company, N.A.
252.73K
0.24%
--
--
Sep 30, 2025
Heuszel (Frank D.)
95.47K
0.09%
--
--
Dec 22, 2025
Two Sigma Investments, LP
59.94K
0.06%
+37.24K
+164.06%
Sep 30, 2025
Geode Capital Management, L.L.C.
45.11K
0.04%
-4.76K
-9.55%
Sep 30, 2025
Susquehanna International Group, LLP
20.96K
0.02%
-9.86K
-31.99%
Sep 30, 2025
State Street Investment Management (US)
11.80K
0.01%
--
--
Sep 30, 2025
Mason & Associates, Inc.
10.00K
0.01%
+10.00K
--
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
